Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCHW) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to 13590.48%.

  • Envoy Medical's EBIT Margin fell 47119000.0% to 13590.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 9824.04%, marking a year-over-year decrease of 21150500.0%. This contributed to the annual value of 8558.22% for FY2024, which is 27484100.0% down from last year.
  • Envoy Medical's EBIT Margin amounted to 13590.48% in Q3 2025, which was down 47119000.0% from 6500.0% recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's EBIT Margin ranged from a high of 3150.88% in Q3 2022 and a low of 14530.0% during Q4 2022
  • Moreover, its 4-year median value for EBIT Margin was 7135.29% (2024), whereas its average is 8250.01%.
  • Its EBIT Margin has fluctuated over the past 5 years, first soared by 74531600bps in 2023, then plummeted by -47119000bps in 2025.
  • Over the past 4 years, Envoy Medical's EBIT Margin (Quarter) stood at 14530.0% in 2022, then soared by 51bps to 7076.84% in 2023, then tumbled by -53bps to 10830.95% in 2024, then decreased by -25bps to 13590.48% in 2025.
  • Its EBIT Margin stands at 13590.48% for Q3 2025, versus 6500.0% for Q2 2025 and 11102.17% for Q1 2025.